Issue: Volume XII No. 12 - August 22, 2005

Innovative AP Reports Created by Path Group

CEO SUMMARY: Too often local pathology groups fail to react to intensified sales competition for the biopsy referrals of clinicians in their community. In Torrance, California, the 30 pathologists of Pathology, Inc. decided it was time to invest capital and resources into developing their own flavor of “value-added” pathology services. These custom-tailored pathology reports are …

Innovative AP Reports Created by Path Group Read More »

Quest Pays $934 Million In Acquisition of LabOne

CEO SUMMARY: In many ways, this acquisition would appear to be the “same old story” of lab consolidation that has marked the lab industry for almost 20 years. Yet, beneath the surface is an unexpected dimension: a motive to use the resources of both companies to better position Quest Diagnostics Incorporated to compete in the …

Quest Pays $934 Million In Acquisition of LabOne Read More »

Picking Winners and Losers For the Molecular Test Menu

CEO SUMMARY: In the 15 years it has operated a molecular diagnostics testing program, Beaumont Reference Laboratory (BRL) has learned important lessons on how to evaluate which specific molecular assays are ready for clinical introduction. It has also learned effective ways to anticipate the clinical and financial success of such assays. Part II of this …

Picking Winners and Losers For the Molecular Test Menu Read More »

Proteomic Tests Poised For Clinical Market

CEO SUMMARY: Proteomics-based technology is developing rapidly. The strategic collaboration announced last month between Ciphergen Biosystems and Quest Diagnostics Incorporated is potentially worth $25 million. It is an expensive bet that next-generation proteomics tests soon to enter the clinical marketplace will provide high clinical utility and give physicians new diagnostic tools. NEW PROTEOMIC-BASED TECHNOLOGIES ARE …

Proteomic Tests Poised For Clinical Market Read More »

“August 22, 2005 Intelligence: Late Breaking Lab News”

In California, some physicians continue to seek illegal kickbacks from clinical laboratories. The problem is widespread enough that the FBI has conducted several “sting operations.” In a jury trial related to the long-running “Durascam” healthcare fraud investigation, a married pair of doctors, Adelina Vorperian, M.D. and Kevork Vorperian, M.D., were convicted on charges of accepting …

“August 22, 2005 Intelligence: Late Breaking Lab News” Read More »

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.